About
Company
Latest News
Contact Us
History
Careers
Policies
Editorial Policies
Open Access Policy
Research and Publication Ethics
Peer-review Policies
Publication Fees
Advertising Policy
Journals
All Journals
Active Journals
Archived Journals
Services
Language Editing
Layout & Production
Graphic Abstracts
Video Abstracts
Submission System
Collaborations
Strategic Collaborators
Journal Membership
Conference Parterships
Insights
Latest Articles
Academic Talks
Interactive Webinars
Academic Support
Author Hub
Editor Hub
Reviewer Hub
Conference Organizer
Expert Lecture
Search
Log In
Home
Volumes
Volume6
Volume6, Issue2 (2023)
Volume
Targeting MYC-driven lymphoma: lessons learned and future directions
How acute myeloid leukemia (AML) escapes from FMS-related tyrosine kinase 3 (FLT3) inhibitors? Still an overrated complication?
Cancer stem cells in drug resistance: an introduction to the e-book covering the special issue on the “Cancer Stem Cells and Drug Resistance”
miR-16-5p enhances sensitivity to RG7388 through targeting <i>PPM1D</i> expression (WIP1) in Childhood Acute Lymphoblastic Leukemia
Review of 5-FU resistance mechanisms in colorectal cancer: clinical significance of attenuated on-target effects
Mitochondria in colorectal cancer stem cells - a target in drug resistance
Fungal mycobiome-mediated immune response: a non-negligible promoter in pancreatic oncogenesis and chemoresistance
Remodeling the tumor microenvironment to overcome treatment resistance in HPV-negative head and neck cancer
Revisiting mechanisms of resistance to immunotherapies in metastatic clear-cell renal-cell carcinoma
Major hurdles of immune-checkpoint inhibitors in pancreatic ductal adenocarcinoma
Importance of <i>ROS1</i> gene fusions in non-small cell lung cancer
The evolving role of DNA damage response in overcoming therapeutic resistance in ovarian cancer
Immune checkpoint inhibitors in ovarian cancer: where do we go from here?
Interaction of pregnane X receptor with hypoxia-inducible factor-1 regulates chemoresistance of prostate cancer cells
Recent advances in access to overcome cancer drug resistance by nanocarrier drug delivery system
Mechanisms and clinical implications in renal carcinoma resistance: narrative review of immune checkpoint inhibitors
Actions for 0 selected articles
Download PDFs >
Cancer Drug Resistance
ISSN 2578-532X (Online)
editorial@cdrjournal.com
Navigation
Contact Us
Sitemap
Follow Us
LinkedIn
Twitter
WeChat
Navigation
Contact Us
Sitemap
Committee on Publication Ethics
https://publicationethics.org/members/cancer-drug-resistance
Portico
All published articles will preserved here permanently:
https://www.portico.org/publishers/oae/
Committee on Publication Ethics
https://publicationethics.org/members/cancer-drug-resistance
Portico
All published articles will preserved here permanently:
https://www.portico.org/publishers/oae/